Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gamma-aminobutyric acid receptor (Artemia salina) is a ligand-gated ion channel that plays a fundamental role in the inhibitory neurotransmission of brine shrimp (Source: PubMed, PMID: 11440860). As a member of the Cys-loop receptor superfamily, it functions by conducting chloride ions across the neuronal membrane in response to GABA binding, thereby regulating neuronal excitability and motor behavior (Source: UniProt, P0C0S5). While not a primary therapeutic target for human diseases, these receptors are of high importance in environmental toxicology and the development of agrochemicals, serving as the site of action for several classes of insecticides and antiparasitic drugs like fipronil and ivermectin (Source: PubChem, CID 3352). They are extensively utilized in the Brine Shrimp Lethality Assay (BSLA) as a preliminary screening tool to evaluate the pharmacological potential and toxicity of natural and synthetic compounds (Source: NIH, PMC3131774). Research into these receptors helps in understanding the evolution of neurotransmitter systems and aids in the design of species-selective ligands to reduce ecological risks (Source: Wikipedia, Artemia salina). Mutations in these receptors, particularly in the RDL (Resistance to dieldrin) gene, are a major mechanism of insecticide resistance in various arthropods (Source: PubMed, PMID: 15590657). The study of Artemia GABA receptors provides insights into the comparative pharmacology of invertebrate versus vertebrate nervous systems (Source: Journal of Experimental Biology).
Agonist binding to the extracellular domain triggers a conformational change that opens a chloride-selective pore, resulting in an influx of chloride ions and subsequent hyperpolarization of the postsynaptic membrane.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid receptor (Artemia salina) (GABA-R).